Airware Labs Corp. (AIRW) 0.1500 $AIRW
AirWare Labs Files Patent Application for Revolutionary Oxygen Cannula Delivery System
Marketwire - Wed Jul 09, 7:10AM CDT
AirWare Labs Corp. (OTCQB: AIRW) today announced the filing of a new patent application for a revolutionary oxygen cannula delivery system, expected to launch later this year. The system will feature a proprietary cannula design, fitted with disposable nasal dilators that diffuse the stream of oxygen as it enters the nasal passage and prevent the nasal dryness, irritation and discomfort commonly reported by cannula users. The nasal dilators also work to open the nasal passage and increase airflow by up to 60%, enhancing the overall effectiveness of oxygen therapy.
AirWare Labs Announces Manufacturing and Sales Expansion Into China
Marketwire - Thu Mar 27, 7:10AM CDT
AirWare Labs Corp. (OTCQB: AIRW) today announced plans to expand manufacturing, distribution and sales of its AIR(R) filtered nasal products in China. Through a joint venture agreement with Eastar Industries, LLC, AirWare Labs' nasal filters will be re-branded and sold in pharmacies throughout China, offering a new line of defense against the world's highest levels of air pollution and avian flu.
AirWare Labs Announces Additions to Executive Management Team
Marketwire - Wed Feb 19, 7:10AM CST
AirWare Labs Corp. (OTCQB: AIRW) today announced additions to its executive management team:
AirWare Labs enters agreement with Breathe Active for national television media campaign
M2 - Wed Feb 12, 7:58AM CST
US-based health consumer company AirWare Labs Corp (OTCQB:AIRW) said on Tuesday that it has entered into a licensing agreement for AIR ALLERGY, AIR ESSENTIALS SLEEP/SNORE and AIR ESSENTIALS HEADACHE medical devices.
AirWare Labs Enters Licensing Agreement With Breathe Active, LLC
Marketwire - Tue Feb 11, 7:10AM CST
AirWare Labs Corp. (OTCQB: AIRW) today announced a licensing agreement with Breathe Active, LLC for its AIR(TM) ALLERGY, AIR ESSENTIALS(TM) SLEEP/SNORE and AIR ESSENTIALS(TM) HEADACHE medical devices. Under the terms of the agreement, Breathe Active will offer these products to the public through a $2 million national television media campaign powered by Harvest Direct, a leading authority in direct response marketing and retail distribution.
AIR ALLERGY(TM) by AirWare Labs Selected as a 2014 Visionary Award Finalist for the VISION(R) Consumer Products Conference
Marketwire - Mon Jan 27, 7:10AM CST
AirWare Labs Corp. (OTCQB: AIRW) today announced that its AIR ALLERGY(TM) Advanced Nasal Filter has been selected as a 2014 Visionary Award Finalist for the VISION(R) Consumer Products Conference in Dallas, January 27-30, 2014.
AirWare Labs With Patented AIR(R) Products Shares Market Outlook
Marketwire - Tue Feb 19, 8:30AM CST
AirWare Labs Corp. (OTCQB: AIRW) today shares the market outlook for its AIR(R) product lineup in context to products sold within the OTC (Over-the-Counter) and Natural/Homeopathic Marketplaces.
AirWare Labs Announces Its Patented AIR(R) Products for Defense Against Flu & Allergy
Marketwire - Tue Jan 29, 8:30AM CST
AirWare Labs Corp. (OTCQB: AIRW) today announced it will expand its sales and promotional marketing efforts of the AIR(R) Allergy product in addition to the Sleep/Snore product as part of its continued commitment to a national rollout at Walgreens 7500 stores.
AirWare Labs Files Patent Application for Revolutionary Oxygen Cannula Delivery System
Marketwire - Wed Jul 09, 7:10AM CDT
AirWare Labs Corp. (OTCQB: AIRW) today announced the filing of a new patent application for a revolutionary oxygen cannula delivery system, expected to launch later this year. The system will feature a proprietary cannula design, fitted with disposable nasal dilators that diffuse the stream of oxygen as it enters the nasal passage and prevent the nasal dryness, irritation and discomfort commonly reported by cannula users. The nasal dilators also work to open the nasal passage and increase airflow by up to 60%, enhancing the overall effectiveness of oxygen therapy.
AirWare Labs Announces Manufacturing and Sales Expansion Into China
Marketwire - Thu Mar 27, 7:10AM CDT
AirWare Labs Corp. (OTCQB: AIRW) today announced plans to expand manufacturing, distribution and sales of its AIR(R) filtered nasal products in China. Through a joint venture agreement with Eastar Industries, LLC, AirWare Labs' nasal filters will be re-branded and sold in pharmacies throughout China, offering a new line of defense against the world's highest levels of air pollution and avian flu.
AirWare Labs Announces Additions to Executive Management Team
Marketwire - Wed Feb 19, 7:10AM CST
AirWare Labs Corp. (OTCQB: AIRW) today announced additions to its executive management team:
AirWare Labs enters agreement with Breathe Active for national television media campaign
M2 - Wed Feb 12, 7:58AM CST
US-based health consumer company AirWare Labs Corp (OTCQB:AIRW) said on Tuesday that it has entered into a licensing agreement for AIR ALLERGY, AIR ESSENTIALS SLEEP/SNORE and AIR ESSENTIALS HEADACHE medical devices.
AirWare Labs Enters Licensing Agreement With Breathe Active, LLC
Marketwire - Tue Feb 11, 7:10AM CST
AirWare Labs Corp. (OTCQB: AIRW) today announced a licensing agreement with Breathe Active, LLC for its AIR(TM) ALLERGY, AIR ESSENTIALS(TM) SLEEP/SNORE and AIR ESSENTIALS(TM) HEADACHE medical devices. Under the terms of the agreement, Breathe Active will offer these products to the public through a $2 million national television media campaign powered by Harvest Direct, a leading authority in direct response marketing and retail distribution.
AIR ALLERGY(TM) by AirWare Labs Selected as a 2014 Visionary Award Finalist for the VISION(R) Consumer Products Conference
Marketwire - Mon Jan 27, 7:10AM CST
AirWare Labs Corp. (OTCQB: AIRW) today announced that its AIR ALLERGY(TM) Advanced Nasal Filter has been selected as a 2014 Visionary Award Finalist for the VISION(R) Consumer Products Conference in Dallas, January 27-30, 2014.
AirWare Labs With Patented AIR(R) Products Shares Market Outlook
Marketwire - Tue Feb 19, 8:30AM CST
AirWare Labs Corp. (OTCQB: AIRW) today shares the market outlook for its AIR(R) product lineup in context to products sold within the OTC (Over-the-Counter) and Natural/Homeopathic Marketplaces.
AirWare Labs Announces Its Patented AIR(R) Products for Defense Against Flu & Allergy
Marketwire - Tue Jan 29, 8:30AM CST
AirWare Labs Corp. (OTCQB: AIRW) today announced it will expand its sales and promotional marketing efforts of the AIR(R) Allergy product in addition to the Sleep/Snore product as part of its continued commitment to a national rollout at Walgreens 7500 stores.
